International AIDS Society


Now 12313 members from 182 countries | 

HIV and Health Systems: Leveraging HIV Scale-up to Strengthen Chronic Disease Services

July 15th and 16th, 2011 - Rome, Italy


Speakers Biographies

Rifat Atun (Global Fund)

Rifat Atun is the Director of Strategy, Performance and Evaluation at the Global Fund to Fight AIDS, Tuberculosis and Malaria. Professor Rifat Atun joined the Global Fund in September 2008 as a member of the Executive Management Team. He is currently the Chair of the Stop TB Partnership Coordinating Board. Before joining the Global Fund, he has worked with the World Bank, World Health Organization, and the UK Department for International Development. His research focuses on uptake of innovations and new technologies in health systems. He was member of the Strategic Technical Advisory Group (STAG) of the World Health Organization for Tuberculosis. He has also serviced as a member of the Advisory Committee for WHO Research Centre for Health Development in Japan. He has published widely on health systems, communicable disease control, and innovation in the biopharmaceutical sector.

Deborah Birx (CDC GAP)

Dr. Deborah Birx is a renowned national and international expert in the field of HIV/AIDS. Beginning her career in 1985 as a trained clinician in immunology, she focused on HIV/AIDS vaccine research and has published over 220 manuscripts in peer-reviewed journals, authored nearly a dozen chapters in scientific publications, as well as developed and patented vaccines. From 1985-1989 she served as an Assistant Chief of the Allergy Immunology Service at Walter Reed Army Medical Center, earning the U.S. Meritorious Service Medal for her leadership in refining, validating, and standardizing an in vivo test of cell-mediated immunity in HIV-infected patients. She was also rewarded for her significant contribution to the field with the U.S. Meritorious Service Medal for her extensive work in organizing and implementing the gp160 vaccine therapy efficacy trial from 1990-1995. Through her professionalism and leadership in the field, she progressed to serve as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed Army Institute of Research from 1996-2005. In this capacity, she led and managed the USMHRP which grew from a budget of $9.6 million and 125 staff located primarily in the U.S. and Thailand, to a budget of approximately $70 million and 900 directly- and indirectly-supported staff in seven countries (U.S., Thailand, Uganda, Tanzania, Kenya, Cameroon, and Nigeria). In October of 2009, the results of the Thai Phase III HIV vaccine clinical trial (RV 144), in which she was significantly involved, were released—representing a significant scientific achievement; which demonstrated that the vaccine regimen was safe and modestly effective in preventing HIV infection. Upon retirement she received the Legion of Merit Award for her groundbreaking research, leadership and management skills. Since 2005, Dr. Birx has served successfully as the Director of CDC’s Division of Global HIV/AIDS (DGHA) where she has utilized her leadership qualities, superior technical skills, and infective passion to achieve tremendous public health impact. She manages an annual budget of more than $1.5 billion and is ultimately responsible for all of the agency’s global HIV/AIDS activities, including providing oversight to nearly 400 staff at headquarters, over 1,500 staff in the field, and more than 43 country offices in Africa, Asia, Caribbean, and Latin America. CDC DGHA’s regional offices and headquarters support an additional 37 countries through technical assistance. Recognized for her longstanding commitment to building capacity and strengthening quality laboratory health services and systems in Africa, in March 2011, Dr. Birx received a Lifetime Achievement Award from the African Society for Laboratory Medicine (ASLM). With her specialized knowledge and decades of international experience in the field of HIV/AIDS, coupled with a passion for implementing and enhancing prevention, care, and treatment programs, she promotes CDC’s mission and unique strengths through the interagency collaboration in achieving broader U.S. Government global goals.

Judith Currier (University of California)

Dr. Currier is Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at University of California, Los Angeles. She is also the Division Chief for Infectious Diseases and the Associate Director of the UCLA Center for Clinical AIDS Research and Education (CARE). Dr. Currier is trained both in Infectious Diseases and Clinical Epidemiology, and her research interests include the treatment and prevention of complications of antiretroviral therapy, gender-related issues in HIV therapy and the evaluation of antiretroviral treatment strategies in resource limited settings.

Wafaa El-Sadr (ICAP)

Wafaa El-Sadr, MD, MPH, is Professor of Medicine and Epidemiology at Columbia University, the Director of the International Center for AIDS Care and Treatment Programs (ICAP) and the Director of the Global Health Initiative at Columbia University’s Mailman School of Public Health. ICAP, the Center she founded and currently directs, works in sub-Saharan Africa and Central Asia in partnership with governmental and non-governmental organizations building in-country capacity for HIV prevention, care and treatment. More than a million individuals living with HIV have gained access to HIV care services and more than 500,000 have received access to life-saving antiretroviral therapy through these programs. ICAP champions a family-focused approach consistent with the one pioneered at Harlem Hospital through multidisciplinary team of providers and based on building meaningful partnerships with governmental and non-governmental organizations within countries. Dr. El-Sadr has also led efforts to support the capacity of health systems through the many programs that ICAP has established. Her work has also advanced the concepts of health systems strengthening globally for the purpose of confronting major health threats faced by communities around the world. Dr. El-Sadr has led the design and implementation of numerous studies that have furthered the understanding of the prevention and treatment of HIV/AIDS, tuberculosis, and other infectious diseases. She has published widely on these topics. In 2008, Dr. El-Sadr was named a John D. and Catherine T. MacArthur Foundation Fellow and in 2009 she was became a member of the Institute of Medicine. Dr. El-Sadr earned her medical degree from Cairo University in Egypt, a masters degree in Public Health in epidemiology from the Mailman School of Public Health at Columbia University, and a masters degree in Public Administration from the Kennedy School for Government at Harvard University.

Eric Goosby (PEPFAR)

Ambassador Eric Goosby serves as the United States Global AIDS Coordinator, leading all U.S. Government international HIV/AIDS efforts. In this role, Ambassador Goosby oversees implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), as well as U.S. Government engagement with the Global Fund to Fight AIDS, Tuberculosis and Malaria. He serves on the Operations Committee that leads the U.S. Global Health Initiative, along with the heads of the U.S. Agency for International Development and the Centers for Disease Control and Prevention. PEPFAR is the cornerstone of the Global Health Initiative, which takes a comprehensive approach to strengthen health systems and improve health outcomes in the developing world. Ambassador Goosby served as CEO and Chief Medical Officer of Pangaea Global AIDS Foundation from 2001 to June 2009. He also previously served as Professor of Clinical Medicine at the University of California, San Francisco. Ambassador Goosby has played a key role in the development and implementation of HIV/AIDS national treatment scale-up plans in South Africa, Rwanda, China, and Ukraine. He focuses his expertise on the scale-up of sustainable HIV/AIDS treatment capacity, including the delivery of HIV antiretroviral drugs, within existing healthcare systems. Ambassador Goosby has extensive international experience in the development of treatment guidelines for use of antiretroviral therapies, clinical mentoring and training of health professionals, and the design and implementation of local models of care for HIV/AIDS. He has worked closely with international partners on the development of successful HIV/AIDS treatment and treatment-based prevention strategies for high-risk populations. Ambassador Goosby has over 25 years of experience with HIV/AIDS, ranging from his early years treating patients at San Francisco General Hospital when AIDS first emerged, to engagement at the highest level of policy leadership. As the first Director of the Ryan White Care Act at the U.S. Department of Health and Human Services, Ambassador Goosby helped develop HIV/AIDS delivery systems in the United States. During the Clinton Administration, he served as Deputy Director of the White House National AIDS Policy Office and Director of the Office of HIV/AIDS Policy of the U.S. Department of Health and Human Services. Ambassador Goosby has longstanding working relationships with leading multilateral organizations, including UNAIDS, the Global Fund and the World Health Organization.

Gottfried Hirnschall (WHO)

Dr Gottfried Hirnschall is the Director of the HIV Department of the World Health Organization (WHO). In this role, Dr Hirnschall oversees the organization's HIV mandate to provide countries with vitally needed normative and policy guidance to deliver HIV services and build health systems. From 1991 to 2000, Dr Gottfried Hirnschall coordinated WHO's support to countries in the area of child and adolescent health. He then joined the HIV Department to develop evidence-based policy recommendations on wide-ranging technical and strategic issues. As Director for Partnerships, External Relations and Communications for WHO's "3 by 5" initiative, Dr Hirnschall engaged a broad range of partners, including people living with HIV, and thereby succeeded in mobilizing support for the unprecedented scale-up of antiretroviral therapy in low-income countries. Between 2005 and 2007, he directed the Caribbean HIV programme of PAHO (Pan-American Health Organization), based in Trinidad and Tobago. He then served as WHO/PAHO Senior Adviser for Latin America between 2007 and 2009. Throughout his career, Dr Hirnschall has given utmost importance to building consensus and fostering collaboration among partners, including the UN family, the Global Fund to fight AIDS, Tuberculosis, and Malaria, the World Bank, bilateral partners, civil society organizations and other advocates. Dr Hirnschall received a Medical Degree from the University of Vienna with a specialization in Family Health, and holds a diploma in Tropical Medicine from the Swiss Tropical and Public Health Institute. Dr Hirnschall also conducted special studies in Health Economics at the London School of Economics and Political Science and obtained a Master's degree in Public Health from the Johns Hopkins University. Dr Hirnschall has completed the Epidemic Intelligence Service at the Centers for Disease Control in Atlanta, USA. He speaks English, German, French and Spanish.

Charles B. Holmes (Office of the U.S. Global AIDS Coordinator)

Charles B. Holmes, MD, MPH- Chief Medical Officer, Office of the US Global AIDS Coordinator. Dr. Holmes completed clinical training in internal medicine and infectious diseases at Massachusetts General Hospital in Boston. He went on to serve as an Instructor of Medicine at Harvard Medical School focusing on outcomes research and the cost-effectiveness of antiretroviral treatment strategies in low -resource settings. In his current role in Washington, he is responsible for providing technical and programmatic leadership on issues related to HIV treatment and PMTCT to headquarters and field staff and serves as Co-Chair of the PEPFAR Adult Treatment and PMTCT Technical Working Groups. Dr. Holmes has also recently led an initiative to promote the use of costing studies and computer-based scenario modeling to improve PEPFAR and national treatment and PMTCT program planning in over 15 countries. He also collaborates with the FDA and the PEPFAR supply chain management systems on issues related to drug quality, safety, cost and supply, and on development of PEPFAR strategies on technical issues such as ARV regimen selection and HIV drug resistance.

Shabbar Jaffar (London School of Hygiene and Tropical Medicine)

Shabbar Jaffar is Professor of Epidemiology at the London School of Hygiene and Tropical Medicine. Involved in various epidemiological studies and randomized trials in Africa for 20 years, his main interests include HIV, HIV/TB, health services/optimizations research, cryptococcal meningitis. He is currently involved in a large RCT of a complex intervention to reduce early mortality associated with antiretroviral therapy in Tanzania and Zambia and was previously co-PI of a large cluster-randomized trial comparing home-based with facility-based delivery of antiretroviral therapy in SE Uganda. He is the Chair of the EDCTP scientific strategy board and Joint Editor of Tropical Medicine and International Health. He is as the head of the Tropical Epidemiology Group.

Bart Janssen (MSF Brussels)

Bart Janssens, MD, Msc PH worked for Médecins Sans Frontières from 1995 to 2006 in (a.o.) Afghanistan, Angola, RDC and Cambodia (2003 - 2006) mainly as medical program coordinator. Since 2010, I work at the MSF HQ in Brussels as Medical coordinator of Operations. Besides my operational work, I try to contribute as much as possible to document some of the experiences in scientific papers.



Elly Tebasoboke Katabira (IAS)

Dr. Elly T Katabira, MBChB, FRCP Edin., is a Professor of Medicine and former Deputy Dean for Research, School of Medicine, College of health Sciences, Makerere University. He was trained as a medical doctor in Makerere University, Kampala, Uganda and later trained as a physician and specialized in Neurology (Manchester UK; 1984). Since his return to Uganda in 1985 he has worked extensively in the field of Care and Support for HIV infected people. He is the Clinical Advisor at the AIDS Clinic in Mulago Hospital and at the Infectious Diseases Institute of Makerere University College of Health Sciences in Uganda. In 1990 he was recognized as a World AIDS Foundation International Scholar. His strength is in the development of treatment and management guidelines for HIV/AIDS and has written several publications and chapters in various books on this topic. His research interest includes clinical trials and operational research issues on various aspects of HIV/AIDS care and support delivery both within institutions and at community level. He has also undertaken several consultancies on HIV/AIDS Care and Support for UNAIDS and WHO both for the headquarters in Geneva and for the African Regional Office as well as for Family Health International. He is also co-Founder of The AIDS Support Organization (TASO) and is their Medical Advisor since 1987. He is a founding member of the Academic Alliance of AIDS Care and Prevention in Africa. In June 2000 he was elected a member of IAS Governing Council in the African Region. Since then he has actively participated in many IAS activities including co-chairing the IAS Industry Liaison Forum (ILF) and as a co-Editor of the Journal of the International AIDS Society (JIAS). Dr. Katabira is also the author of more than 200 published scientific articles and abstracts.

Peter Lamptey (Family Health International)

Dr. Peter Lamptey is President of Public Health Programs at FHI. He is an internationally recognized public health physician and expert on developing countries, with particular expertise in communicable and non-communicable diseases. With a career at FHI spanning more than 25 years, he has been instrumental in establishing the organization as one of the world’s leading international NGOs in implementing HIV/AIDS prevention, care, treatment, and support programs. From 1987 to 2007, Dr. Lamptey directed several key USAID-funded projects, which encompassed HIV/AIDS programs in over 65 countries in Africa, Asia, Latin America, the Caribbean, Eastern Europe, and the Middle East. Born in Ghana, Dr. Lamptey worked on a USAID-funded Danfa Comprehensive Rural Health Family Planning Project (1973-1976), which was implemented by UCLA and the University of Ghana Medical School. He received his medical degree from the University of Ghana, a master’s degree in public health from UCLA and a doctorate in public health from the Harvard School of Public Health. Dr. Lamptey currently serves on the CSIS Commission on Smart Global Health Policy, the Global HIV Prevention Working Group and as a member of Institute of Medicine’s Committee of the National Academies on Promoting Cardiovascular Health in Developing Countries.

Chewe Luo (UNICEF)

Dr Luo, a pediatrician and public health specialist from Zambia, holds a medical degree from Zambia and did her postgraduate training up to PhD level at the University of Liverpool in the UK. She has over 15 years extensive experience in both HIV research and programming. She is a senior programme adviser and technical team leader for country programme HIV scale up in Programme Division with UNICEF headquarters in New York. She has previously served as a UNICEF HIV regional adviser for Eastern and Southern Africa in Nairobi and as a UNICEF HIV technical adviser in Botswana at a time when Botswana government was scaling up its PMTCT programme and initiating its HIV treatment programme. Before joining UNICEF She worked as a pediatrician at the University Teaching Hospital in Zambia where she worked as a pediatrician and spearheaded key infectious disease research related to malnutrition, diarrhoeal disease, tuberculosis and HIV.

Jean-Paul Moatti (ANRS)

Professor Jean-Paul Moatti is an internationally recognized expert in the field of health economics, who has had a major impact in regard to the problem of HIV disease. He has been a member of numerous World Health Organization, Global Fund, UNAIDS and UNITAID committees on this topic, and has loudly argued that providing worldwide access to HIV/AIDS drugs on a urgent basis is a strategy that will save both lives and money in all countries. Professor Moatti obtained his PhD at the University of Paris and is currently a Professor of Economics at the University of the Mediterranean in Marseille, France. He has been recently appointed Director of the Institute of Public Health of AVIESAN (the French equivalent of the British MRC or US NIH). He has published numerous papers in the fields of HIV and health economics and has received multiple awards for his research in these areas.

Sania Nishtar (Heartfile Pakistan)

Sania Nishtar is the founder and president of the NGO think tank, Heartfile, which today is the most powerful health policy voice in Pakistan and is recognized as a model for replication in other developing countries. Her areas of interests are health systems, global health, broader issues of governance and public-private relationships. In Pakistan her pioneering work in the health sector has inspired new initiatives and has shaped policies on health reform and non-communicable diseases. She is also the founder of Pakistan’s Health Policy Forum and provides support to many agencies in an advisory role. She additionally sits on many governing boards and is a visiting faculty to many educational institutions. Within Pakistan, she is also a voice to catalyze change at the broader governance level as an op-ed columnist in Pakistan’s largest English newspaper. Internationally, Sania Nishtar’s scope of work has several dimensions. She is a member of many Expert Working Groups and Task Forces of the World Health Organization and is currently a member of the board of the International Union for Health Promotion and the Alliance for Health Policy and Systems Research. She is also a member of the World Economic Forum's Global Agenda Council, the Clinton Global Initiative, the Ministerial Leadership Initiative for Global Health and many other international initiatives. She has formerly been on several international Boards, and has chaired several global campaigns and programs. She has also been an advisor to WHO on numerous occasions, has published over 100 journal articles and is the author of 6 books. She speaks to audiences around the world and has been extensively published in and quoted in the media. Sania Nishtar is the recipient of Pakistan’s Sitara-e-Imtiaz, the European Societies Population Science Award, 16 gold medals and many accolades of the International Biographical Centre, Cambridge and the American Biographical Center. Sania Nishtar holds a Fellowship of the Royal College of Physicians of London and a Ph.D.

Peter Piot (London School of Hygiene and Tropical Medicine)

Peter Piot MD PhD is the Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. In 2009-2010 he was the Director of the Institute for Global Health at Imperial College, London. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of WHO. Dr. Piot co-discovered the Ebola virus in Zaire in 1976, and led research on AIDS, women’s health, and public health in Africa. He was a professor of microbiology at the Institute of Tropical Medicine, Antwerp, the Free University of Brussels, and the University of Nairobi, was a Senior Fellow at the University of Washington, a Scholar in Residence at the Ford Foundation, and a Senior Fellow at the Bill and Melinda Gates Foundation. He held the 2009 chair “Knowledge against poverty” at the College de France in Paris. He is a member of the Institute of Medicine of the US National Academy of Sciences, of the Académie Nationale de Médicine of France, and of the Royal Academy of Medicine of his native Belgium, and a fellow of the Royal College of Physicians. He is the President of the King Baudouin Foundation, was knighted as a baron in 1995, and published over 500 scientific articles and 16 books.

Kaushik Ramaiya (International Diabetes Federation)

Dr Kaushik Ramaiya is Consultant Physician and Chief Executive Officer at Shree Hindu Mandal Hospital, Dar es Salaam, Tanzania; Hon. Lecturer at the Department of Medicine of Muhimbili University of Health Sciences, Dar es Salaam; Hon General Secretary of Tanzania Diabetes Association and Vice President, International Diabetes Federation. He also serves on several Boards including National Health Insurance Fund (Tanzania), Muhimbili National Hospital (Tanzania), Tanganyika Medical Council, and World Diabetes Foundation (Denmark). He was previously the Chair of IDF Africa Region (2000-2006). Dr Ramaiya received his basic medical training at the University of Bombay, India, and completed his postgraduate training in Internal Medicine at the University of Dar es Salaam, Tanzania. Dr Ramaiya has been actively involved in research on diabetes for many years. He specialized, among other topics, on glucose tolerance and cardiovascular disease risk factors and mainly focused on Hindu communities living in Africa. Dr Ramaiya greatly contributed to a better understanding of diabetes in the African region. His research on the role of ethnic differences is of great value. Dr Ramaiya has also investigated on the status of diabetes care in Africa, the economic costs of diabetes and its consequences. He has held many oral presentations and published several articles on the above topics. At present, Dr Ramaiya is working on developing comprehensive program on type 1 diabetes in children in Tanzania, HIV/AIDS and its interaction with diabetes, hypertension and cardiovascular diseases, and , economic burden of diabetes & cardiovascular diseases.

Srinath Reddy (Public Health Foundation of India)

Prof. K. Srinath Reddy is presently President, Public Health Foundation of India (PHFI) and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS). He has recently been appointed as the First Bernard Lown Visiting Professor of Cardiovascular Health at the Harvard School of Public Health and is also an Adjunct Professor of the Rollins School of Public Health, Emory University. PHFI is engaged in capacity building in Public Health in India through education, training, research, policy development, health communication and advocacy. Having trained in cardiology and epidemiology, Prof. Reddy has been involved in several major international and national research studies including the INTERSALT global study of blood pressure and electrolytes, INTERHEART global study on risk factors of myocardial infarction, national collaborative studies on epidemiology of coronary heart disease and community control of rheumatic heart disease. He has served on many WHO expert panels and chairs the Foundations Advisory Board of the World Heart Federation. He is a member of World Economic Forum’s Global Health Board. He also chairs the Core Advisory Group on Health and Human Rights for the National Human Rights Commission of India. He is a member of the National Science and Engineering Research Board of Government of India. He is presently chairing the High Level Expert Group on Universal Health Coverage, set up by the Planning Commission of India. He also serves as the President, of the National Board of Examinations which deals with post-graduate medical education in India.

Sinata Koulla Shiro (MOH Cameroon)

Sinata Koulla-Shiro is a Professor of Microbiology and Infectious Diseases at the Faculty of Medicine and Biomedical Sciences of the University of Yaoundé 1 in Cameroon. She studied medicine and obtained her M.D at this same Faculty in 1978. After working for 4 years in the Unit of internal medicine at the Yaoundé Central hospital, she obtained in 1982, a World Health Organisation fellowship for a post graduate study at the faculty of medicine, University of Geneva, Switzerland where she obtained a diploma in Internal Medicine in 1985. During these studies she focused particularly on infectious diseases and also specialised in Medical Bacteriology. She is a consultant at the Infectious Disease service of Yaoundé Central Hospital where she has been chief of service from 1987 to 2003. She was the Coordinator of Cameroon National AIDS Program between 1999 and 2002 and is the Vice- chair of the National AIDS Control Committee (NACC) since 2002. Between 2002 and 2008 she was first Technical Advisor to the Cameroon Minister of public health in charge in particular of HIV/AIDS matters and research at the Minister’s cabinet. She is currently since 2008, the Chief of the Division of Health Operations Research in the same ministry. She is a board member of Centre Pasteur of Cameroon and also of the Institute of Medical Research and Medicinal Plant at the Cameroon Ministry of Scientific Research and Innovation.. She is also the local Coordinator of the Cameroon Site of the French Agency for Research on AIDS and Hepatitis (ANRS) since January 2005. She was a member of the WHO “3 by 5” Evaluation Team Steering Committee and has been an active member of Cameroon Country Coordinating Mechanism (CCM) of the Global Fund to fight AIDS, Tuberculosis and Malaria until lately. She was appointed as a foreign member of the Scientific Council of the French Institute of Research for Development (IRD) in 2008. She is an author of over 75 publications on Bacterial infections, HIV/AIDS and other Infectious diseases. Her working languages are English and French.

Velephi Okello (MOH Swaziland)

Dr. Velephi Okello is the National Coordinator for the HIV Care and Treatment (ART) Programme in the Ministry of Health, Swaziland. She has been in this position for the past 6 and a half years. She graduated from Mbarara University of Science and Technology in 2001 with a Bachelor of Medicine and Bachelor of Surgery Degree. In 1991, she graduated from the University of Swaziland with a Bachelor of Science Degree, majoring in Biology and Chemistry. She has vast experience in providing leadership in the ART Programme and in developing strategies for the integration of antiretroviral therapy services within TB treatment services and PMTCT services. Dr. Velephi Okello has been accepted to Harvard School of Public Health for 2011/12, to pursue a Masters in Public Health Degree with majors in Health Care Management and Policy.

 

 
Biographies for download

Click here to download the speakers biographies in PDF format.